H. Tejada Meza

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain

H. Tejada Meza, Álvaro Lambea‐Gil, A. Sancho Saldaña et al. · International Journal of Stroke · 2020 · 81 citations · Full text

Life Sciences, Health Sciences, Infectious Diseases +14

Ischaemic stroke in the time of coronavirus disease 2019

H. Tejada Meza, A. Sancho Saldaña, C. Yus et al. · European Journal of Neurology · 2020 · 36 citations · Full text

Life Sciences, Health Sciences, Infectious Diseases +9

Impact of COVID‐19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain

H. Tejada Meza, A. Sancho Saldaña, Maite Martínez-Zabaleta et al. · European Journal of Neurology · 2020 · 35 citations · Full text

Medicine, Clinical Sciences, Cerebrovascular Surgery +15

Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19

João Pedro Marto, Davide Strambo, George Ntaios et al. · Neurology · 2022 · 31 citations · Full text

Medicine, Infectious Diseases, Interventional Cardiology +16